Teladoc Health, Inc. (NYSE:TDOC) Receives Consensus Recommendation of “Hold” from Brokerages

Posted by Defense World Staff on Jun 7th, 2023

Shares of Teladoc Health, Inc. (NYSE:TDOC – Get Rating) have received a consensus rating of “Hold” from the twenty-nine brokerages that are currently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, thirteen have issued a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year price objective among brokerages that have covered the stock in the last year is $33.14.

TDOC has been the subject of a number of research analyst reports. Wells Fargo & Company cut their target price on shares of Teladoc Health from $28.00 to $23.00 and set an “equal weight” rating for the company in a research note on Monday, March 6th. Barclays lifted their target price on shares of Teladoc Health from $28.00 to $29.00 in a research note on Thursday, April 27th. SVB Leerink raised shares of Teladoc Health from a “market perform” rating to an “outperform” rating and set a $34.00 price target for the company in a report on Thursday, February 23rd. SVB Securities raised shares of Teladoc Health from a “market perform” rating to an “outperform” rating and set a $34.00 price target for the company in a report on Thursday, February 23rd. Finally, 58.com reaffirmed a “maintains” rating on shares of Teladoc Health in a report on Thursday, April 27th.

Insider Activity

In other news, insider Vidya Raman-Tangella sold 15,372 shares of the firm’s stock in a transaction on Tuesday, May 2nd. The shares were sold at an average price of $26.76, for a total transaction of $411,354.72. Following the completion of the transaction, the insider now owns 25,620 shares of the company’s stock, valued at $685,591.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, insider Vidya Raman-Tangella sold 15,372 shares of the stock in a transaction on Tuesday, May 2nd. The shares were sold at an average price of $26.76, for a total transaction of $411,354.72. Following the completion of the sale, the insider now directly owns 25,620 shares in the company, valued at $685,591.20. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, SVP Daniel Trencher sold 1,000 shares of the firm’s stock in a transaction on Monday, April 17th. The stock was sold at an average price of $25.30, for a total transaction of $25,300.00. Following the completion of the sale, the senior vice president now owns 24,520 shares of the company’s stock, valued at $620,356. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 19,464 shares of company stock valued at $510,470. Insiders own 1.63% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the business. EverSource Wealth Advisors LLC bought a new position in shares of Teladoc Health in the fourth quarter valued at $25,000. Oliver Lagore Vanvalin Investment Group lifted its position in shares of Teladoc Health by 94.3% during the third quarter. Oliver Lagore Vanvalin Investment Group now owns 1,030 shares of the health services provider’s stock valued at $26,000 after purchasing an additional 500 shares in the last quarter. Acadian Asset Management LLC bought a new position in shares of Teladoc Health during the first quarter valued at about $27,000. Dark Forest Capital Management LP lifted its position in shares of Teladoc Health by 408.2% during the first quarter. Dark Forest Capital Management LP now owns 1,245 shares of the health services provider’s stock valued at $32,000 after purchasing an additional 1,000 shares in the last quarter. Finally, Quarry LP bought a new position in shares of Teladoc Health during the first quarter valued at about $35,000. 84.14% of the stock is owned by institutional investors.

Teladoc Health Stock Up 2.4 %

Shares of TDOC opened at $25.38 on Wednesday. The stock has a market cap of $4.15 billion, a price-to-earnings ratio of -0.58 and a beta of 1.07. The company has a quick ratio of 3.25, a current ratio of 3.37 and a debt-to-equity ratio of 0.67. Teladoc Health has a 12 month low of $21.60 and a 12 month high of $44.66. The company has a 50-day moving average price of $25.31 and a two-hundred day moving average price of $26.23.

Teladoc Health (NYSE:TDOC – Get Rating) last posted its earnings results on Wednesday, April 26th. The health services provider reported ($0.37) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.51) by $0.14. Teladoc Health had a negative net margin of 285.51% and a negative return on equity of 5.81%. The company had revenue of $629.24 million during the quarter, compared to analysts’ expectations of $617.55 million. Equities analysts predict that Teladoc Health will post -1.38 EPS for the current fiscal year.

About Teladoc Health

(Get Rating)

Teladoc Health, Inc engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services.

Analyst Recommendations for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.